Camlin Fine Sciences Allots 41,06,181 Equity Shares for Vinpai Acquisition
Camlin Fine Sciences allots 41,06,181 equity shares at ₹247.69 each, totaling ₹101.70 crore, for acquiring Vinpai shares, increasing equity capital to ₹19,20,86,613. The acquisition of 78.68% stake in Vinpai is now complete.
The acquisition of Vinpai is expected to bring technological advancements and increase the product range of the company. It will also give additional revenue, which are not available hitherto Vinpai.
The announcement details the successful allotment of shares for a strategic acquisition, indicating growth and expansion for the company.
* Camlin Fine Sciences Limited allotted 41,06,181 fully paid-up equity shares at ₹ 247.69 per share. * The allotment is for a consideration other than cash, specifically for the acquisition of ordinary shares of Vinpai. * The total consideration for the allotment is ₹ 101.70 crore. * The paid-up equity share capital of the company increased from ₹ 18,79,80,432 to ₹ 19,20,86,613. * The allotment was approved by the Securities Issue and Allotment Committee on November 30, 2025. * The allotment completes the transaction contemplated in the share purchase agreement (SPA) with Vinpai. * Vinpai is an ingredien'tech company specializing in natural alternatives to chemical additives, with a turnover of €9.157 million in 2024 (approximately ₹ 82.41 crore). * The company acquired 27,23,316 ordinary shares constituting a majority stake in Vinpai representing 78.68% of Vinpai’s outstanding share capital.
What to do with a filing like this
Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under preferential allotment. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.